study

(redirected from Dose-ranging study)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

study

1. a drawing, sculpture, etc., executed for practice or in preparation for another work
2. a musical composition intended to develop one aspect of performing technique
3. Theatre a person who memorizes a part in the manner specified

study

A drawing executed as an educational exercise, produced as a preliminary to a final work or made record observations.
See also: Design drawing

study

1. A room or alcove of a house or apartment used primarily as a place for reading, writing, and study. It often embodies the features of a private office and private library.
2. A preliminary sketch or drawing to facilitate the development of a design.
References in periodicals archive ?
A placebo-controlled, dose-ranging study with a total of 338 patients was done to assess the blood pressure-lowering effects of a controlled-release (CR) once-daily formulation of carvedilol.
US-based biopharmaceutical company AbbVie (NYSE: ABBV) has received positive top-line results from the Phase 2b randomised, placebo-controlled, dose-ranging study of upadacitinib (ABT-494), an investigational, once-daily oral JAK1-selective inhibitor, in adult patients with moderate to severe atopic dermatitis not adequately controlled by topical treatments, or for whom topical treatments were not medically advisable, the company said.
The 455-patient randomised, double-masked, vehicle-controlled, dose-ranging study (ClinicalTrials.
A placebo-controlled, dose-ranging study with a total of 338 patients was done to assess the blood pressure--lowering effects of a controlled-release (CR) once-daily formulation of carvedilol.
A placebo-controlled, dose-ranging study with a total of 338 patients was done to assess the blood-pressure lowering effects of a controlled-release (CR) once-daily formulation of carvedilol.
Tokyo, Japan, Sept 6, 2005 - (JCNN) - Sosei, a Japanese biopharmaceutical company, announced on September 5 that its wholly owned UK subsidiary Arakis has started a phase IIb dose-ranging study of AD 452, an investigational drug for the treatment of rheumatoid arthritis (RA).
The objective of the randomized, double-blind, placebo- controlled, Phase Ib dose-ranging study was to evaluate the safety and tolerability of multiple oral dosing regimens of SCIO-469 in healthy volunteers.
Donovan reported on 494 moderately hypercholesterolemic patients who participated in a double-blind, placebocontrolled, dose-ranging study of colesevelam.
Dose-Ranging Study (Phase II; N=68): A 7-week randomized, double-blind study consisting of a 4-week baseline period, 3-week blinded titration period and 4-week blinded maintenance period, followed by open-label continuation or 3-week taper period.
ACTION 2 was a Phase 2b multicenter, double-blind, placebo-controlled, randomized, dose-ranging study with a 90 day follow up to evaluate the safety and efficacy of natalizumab primarily in patients with moderate severity acute ischemic stroke.
Bristol-Myers Squibb Company today announced the first report of five-year overall survival (OS) data from the Phase 1 dose-ranging study CA209-003 evaluating Opdivo in patients with previously treated advanced non-small cell lung cancer (NSCLC; n=129).
Antibe will now initiate two larger Phase 2 double-blind trials: a placebo-controlled dose-ranging study to determine the go-to-market dose, and an active comparator trial to demonstrate superior GI safety.